Literature DB >> 7527495

Nitric oxide in skeletal muscle.

L Kobzik1, M B Reid, D S Bredt, J S Stamler.   

Abstract

Reactive oxygen intermediates modulate skeletal muscle contraction, but little is known about the role of nitric oxide (NO). Here we show that rat skeletal muscle expresses neuronal-type NO synthase and that activity varies among several respiratory and limb muscles. Immunohistochemistry showed prominent staining of type II (fast) fibre cell membranes with antibodies against neuronal-type NO synthase. NO synthase activity in muscles correlated with type II fibre density. Resting diaphragm muscle produced detectable NO chi, but no reactive oxygen intermediates. In contrast, actively contracting muscle generated increased levels of reactive oxygen intermediates. Contractile function was augmented by blockers of NO synthase, extracellular NO chelation, and guanylyl cyclase inhibition; it was depressed by NO donors and by increased levels of cyclic GMP. Force-frequency plots of different muscles showed an inverse correlation between NO synthase activity and force development. Our results support two physiological functions of NO in skeletal muscle. The first is to promote relaxation through the cGMP pathway. The second is to modulate increases in contraction that are dependent on reactive oxygen intermediates and which are thought to occur through reactions with regulatory thiols on the sarcoplasmic reticulum.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7527495     DOI: 10.1038/372546a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  177 in total

Review 1.  Aging-related changes in skeletal muscle. Mechanisms and interventions.

Authors:  L Larsson; B Ramamurthy
Journal:  Drugs Aging       Date:  2000-10       Impact factor: 3.923

Review 2.  Respiratory muscle function and free radicals: from cell to COPD.

Authors:  L M Heunks; P N Dekhuijzen
Journal:  Thorax       Date:  2000-08       Impact factor: 9.139

Review 3.  NO as a signalling molecule in the nervous system.

Authors:  Juan V Esplugues
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

4.  An investigation of the effects of zaprinast, a PDE inhibitor, on the nitrergic control of the urethra in anaesthetized female rats.

Authors:  Alexandra Wibberley; Philip A Nunn; Alasdair M Naylor; Andrew G Ramage
Journal:  Br J Pharmacol       Date:  2002-06       Impact factor: 8.739

Review 5.  The exercise-induced growth hormone response in athletes.

Authors:  Richard J Godfrey; Zahra Madgwick; Gregory P Whyte
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

Review 6.  Nitric oxide (NO) and obstructive sleep apnea (OSA).

Authors:  James S J Haight; Per Gisle Djupesland
Journal:  Sleep Breath       Date:  2003-06       Impact factor: 2.816

7.  T-1032, a cyclic GMP phosphodiesterase-5 inhibitor, acutely blocks physiologic insulin-mediated muscle haemodynamic effects and glucose uptake in vivo.

Authors:  Hema Mahajan; Stephen M Richards; Stephen Rattigan; Michael G Clark
Journal:  Br J Pharmacol       Date:  2003-10-27       Impact factor: 8.739

Review 8.  Exercise and the nitric oxide vasodilator system.

Authors:  Andrew Maiorana; Gerard O'Driscoll; Roger Taylor; Daniel Green
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

9.  Neuronal nitric oxide synthase is heterogeneously distributed in equine myofibers and highly expressed in endurance trained horses.

Authors:  Fernando J Gondim; Luzia V Modolo; Gerson E R Campos; I Salgado
Journal:  Can J Vet Res       Date:  2005-01       Impact factor: 1.310

10.  Muscle-specific AMPK β1β2-null mice display a myopathy due to loss of capillary density in nonpostural muscles.

Authors:  Melissa M Thomas; David C Wang; Donna M D'Souza; Matthew P Krause; Andrew S Layne; David S Criswell; Hayley M O'Neill; Michael K Connor; Judy E Anderson; Bruce E Kemp; Gregory R Steinberg; Thomas J Hawke
Journal:  FASEB J       Date:  2014-02-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.